Avricore Health Inc. (OTCQB: AVCRF) is a health innovator, applying technologies at the forefront of science to core health issues at the community pharmacy level. CEO Hector Bremner joins us to discuss the company’s flagship HealthTab platform and the point-of-care-testing market.
GB Sciences (OTCQB: GBLX) is a plant-inspired, biopharmaceutical research and development company creating patented, disease-targeted formulations of cannabis- and other plant-inspired therapeutic mixtures for the prescription drug market. President & Chief Scientific Officer, Andrea Small-Howard, joins us to discuss how the company differentiates itself in the crowded biopharmaceutical field.
Openn Negotiation (OTCQB: OPNNF) operates as a property technology company in Australia, New Zealand, Canada, and the United States. It offers a cloud-based software platform to support real estate agents in selling property online by facilitating the negotiation process, streamlining digital contracting, and automating communication tools that enhance property transactions. Executive Director, CTO, & North American President, Duncan Anderson, joins us to discuss the digital solutions Openn provides in the real estate industry.
OpenLocker Holdings (OTCQB: OLKR) is a technology platform for athletes and brands to redefine and unlock consumer and fan value. CEO Howard Gostfrand joins us to discuss the company’s unique offering and feedback it has had from athletes and the industry.
S-Ventures (OTCQB: SVTPF) identifies investment opportunities in the health & wellness, organic food and wellbeing sectors within the UK and Europe. CEO Scott Livingston joins us to discuss how the company’s business model works.